Clinical Trial: Soluble Programmed Death 1 (sPD1) is a Diagnostic Biomarker of ILD in Patients With Rheumatoid Arthritis Disease

Media coverage

• Title	Clinical Trial: Soluble Programmed Death 1 (sPD1) is a Diagnostic Biomarker of ILD in Patients With Rheumatoid Arthritis Disease
  Media name/outlet	Health Daily Digest (Ht Media)
  Country/Territory	India
  Date	11/4/21
  Persons	Omar Mohammed Abdelsaboor

• Title	Clinical Trial: Soluble Programmed Death 1 (sPD1) is a Diagnostic Biomarker of ILD in Patients With Rheumatoid Arthritis Disease
  Media name/outlet	US Fed News
  Country/Territory	United States
  Date	11/4/21
  Persons	Omar Mohammed Abdelsaboor